A recent United Kingdom study has claimed drinking coffee can lower the risk of the commonest type of liver cancer.
The study has been conducted by researchers at the Queen’s University Belfast in Northern Ireland.
Published in the British Journal of Cancer, the study took into consideration the coffee-drinking habits of 471,779 participants.
The research spanned 7.5 years, during which the participants’ coffee-drinking was monitored.
What does the study say?
The study showed people who drank coffee had a lower risk of getting hepatocellular carcinoma (HCC) than those who didn’t. HCC is the most common form of liver cancer.
According to the study, those who drank coffee were 50 percent less likely to develop HCC later in life.
The study’s lead author Kim Tu Tran suggested that people already drinking coffee should continue to do so.
He was quoted by a Press Trust of India report as saying: “That is because coffee contains antioxidants and caffeine, which may protect against cancer. However, drinking coffee is not as protective against liver cancer as stopping smoking, cutting down on alcohol or losing weight.”
The researchers also looked at the effect of coffee on cancers of the bowel and the stomach, but did not find anything significant.
Other effects of coffee
Earlier this year, research showed that coffee was not as bad for arterial stiffness as was earlier thought.
Led by Professor Steffen Petersen from the William Harvey Research Institute of the Queen Mary University of London, it was conducted on 8,000 people.
The study’s data analysis lead Dr Kenneth Fung was at that time quoted as saying: “Whilst we can’t prove a causal link in this study, our research indicates coffee isn’t as bad for the arteries as previous studies would suggest.”
Joel Winston, a spokesperson from the university and for the research team, later told Times of Food via email that the study also took into account the ethnicity of the participants.